Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Kaj Blennow

Professor/ chief physician

Kaj Blennow
Professor/ chief physician
kaj.blennow@clinchem.gu.se

Postal Address: Su sahlgrenska, 41345 Göteborg
Visiting Address: Laborativ neurovetenskap , Göteborg


Department of Psychiatry and Neurochemistry at Institute of Neuroscience and Physiology (More Information)
Blå stråket 15, vån 3 SU/Sahlgrenska
413 45 Göteborg
031-342 10 00
Visiting Address: Blå stråket 15, vån 3 SU/Sahlgrenska , 413 45 Göteborg

About Kaj Blennow

Latest publications

Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity
C. Meregalli, G. Fumagalli, P. Alberti, A. Canta, A. Chiorazzi et al.
Archives of Toxicology, Journal article 2020
Journal article

A beta deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer's disease
N. Mattsson-Carlgren, E. Andersson, S. Janelidze, R. Ossenkoppele, P. Insel et al.
Science Advances, Journal article 2020
Journal article

Longitudinal change in regional brain volumes with exposure to repetitive head impacts.
Charles Bernick, Guogen Shan, Henrik Zetterberg, Sarah Banks, Virendra R Mishra et al.
Neurology, Journal article 2020
Journal article

Neurofilament-Light in Former Athletes: A Potential Biomarker of Neurodegeneration and Progression.
Foad Taghdiri, Namita Multani, Miracle Ozzoude, Apameh Tarazi, Mozhgan Khodadadi et al.
European journal of neurology, Journal article 2020
Journal article

Lower Left Ventricular Ejection Fraction Relates to Cerebrospinal Fluid Biomarker Evidence of Neurodegeneration in Older Adults.
Hailey A Kresge, Dandan Liu, Deepak K Gupta, Elizabeth E Moore, Katie E Osborn et al.
Journal of Alzheimer's disease : JAD, Journal article 2020
Journal article

Contribution of CSF biomarkers to early-onset Alzheimer's disease and frontotemporal dementia neuroimaging signatures
N. Falgas, M. Ruiz-Peris, A. Perez-Millan, R. Sala-Llonch, A. Antonell et al.
Human Brain Mapping, Journal article 2020
Journal article

Neuroinflammatory markers associate with cognitive decline after major surgery: Findings of an explorative study
Mattias Danielson, A. Wiklund, F. Granath, Kaj Blennow, S. Mkrtchian et al.
Annals of Neurology, Journal article 2020
Journal article

Showing 1141 - 1150 of 1177

2004

Cerebrospinal fluid protein biomarkers for Alzheimer's disease.
Kaj Blennow
NeuroRx : the journal of the American Society for Experimental NeuroTherapeutics, Review article 2004
Review article

CSF biomarkers for mild cognitive impairment.
Kaj Blennow
Journal of internal medicine, Review article 2004
Review article

Altered thalamic membrane phospholipids in schizophrenia: a postmortem study.
Andrea Schmitt, Katrin Wilczek, Kaj Blennow, Athanasios Maras, Alexander Jatzko et al.
Biological psychiatry, Journal article 2004
Journal article

Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study.
Harald Hampel, Katharina Buerger, Raymond Zinkowski, Stefan J Teipel, Alexander Goernitz et al.
Archives of general psychiatry, Journal article 2004
Journal article

Cerebrospinal fluid markers for early and accurate diagnosis of Alzheimer's disease
Henrik Zetterberg, Kaj Blennow
Neurodégénérescence et vieillissement cerebral. Eds BF Michel & JM Verdier., Solal, Chapter in book 2004
Chapter in book

APOE epsilon 4 allele is associated with reduced cerebrospinal fluid levels of A beta 42
J.A. Prince, Henrik Zetterberg, Niels Andreasen, J. Marcusson, Kaj Blennow
NEUROLOGY, Journal article 2004
Journal article

Showing 1141 - 1150 of 1177

Page Manager: Webbredaktör|Last update: 9/1/2015
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?